Journal of global antimicrobial resistance · 2025
Therapeutic effects of zinc nanoparticles green synthesized by Ferula macercolea extract against chronic toxoplasmosis in mice.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alanazi Abdullah D, Alghabban Areej Jameel
Аннотация
OBJECTIVES: The present study aimed to green synthesize and characterize the zinc nanoparticles (ZNP) and evaluate its potency to control Toxoplasma gondii infection in mice by stimulating the immune system, antioxidant activity, and anti-inflammatory effects.
METHODS: By in vivo, T. gondii infected mice were orally treated by ZNP (5-20 mg/kg) for 14 d. The number and size of tissue cysts, oxidant-antioxidant enzymes, the expression of inflammatory cytokines, apoptotic, and pathogenicity-related factors were evaluated by real-time polymerase chain reaction.
RESULTS: ZNP ranged in size from 10 to 70 nm with an average size of 45.7 ± 19.4 nm. ZNP treatment resulted in a significant reduction in the number and size of tissue cysts (P < 0.05). The oral administration of infected mice with ZNP caused a considerable decrease in malondialdehyde levels and a marked increase (P < 0.001) in the activity of the antioxidant enzymes glutathione peroxidase and superoxide dismutase. ZNP administration triggered a significant reduction in the expression levels of the genes of interleukin-1β, tumour necrosis factor-α, nuclear factor kappa B, bradyzoite antigen-1, and B-cell lymphoma-2. Conversely, there was an increase in the expression levels of the genes of IL-10, Serpin A3k, caspase-3, and Bcl-2-associated X protein (P < 0.001).
CONCLUSIONS: In summary, the recent investigation illustrated that ZNP demonstrates promising in vivo effects against T. gondii infection in mice. These effects are ascribed to its antioxidant properties, anti-inflammatory characteristics through the inhibition the specific inflammatory cytokines, and its ability to inhibit pathogenicity in mice without any observable signs of toxicity.
METHODS: By in vivo, T. gondii infected mice were orally treated by ZNP (5-20 mg/kg) for 14 d. The number and size of tissue cysts, oxidant-antioxidant enzymes, the expression of inflammatory cytokines, apoptotic, and pathogenicity-related factors were evaluated by real-time polymerase chain reaction.
RESULTS: ZNP ranged in size from 10 to 70 nm with an average size of 45.7 ± 19.4 nm. ZNP treatment resulted in a significant reduction in the number and size of tissue cysts (P < 0.05). The oral administration of infected mice with ZNP caused a considerable decrease in malondialdehyde levels and a marked increase (P < 0.001) in the activity of the antioxidant enzymes glutathione peroxidase and superoxide dismutase. ZNP administration triggered a significant reduction in the expression levels of the genes of interleukin-1β, tumour necrosis factor-α, nuclear factor kappa B, bradyzoite antigen-1, and B-cell lymphoma-2. Conversely, there was an increase in the expression levels of the genes of IL-10, Serpin A3k, caspase-3, and Bcl-2-associated X protein (P < 0.001).
CONCLUSIONS: In summary, the recent investigation illustrated that ZNP demonstrates promising in vivo effects against T. gondii infection in mice. These effects are ascribed to its antioxidant properties, anti-inflammatory characteristics through the inhibition the specific inflammatory cytokines, and its ability to inhibit pathogenicity in mice without any observable signs of toxicity.